Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Koki Oyama

Matched on ORCID iD 0009-0001-8610-0277; OpenAlex author ID A5070426564. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 4 papers · 2025: 2 papers

Papers 8

  1. Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. Co-author DOI 10.1007/s00432-025-06095-z↗
  2. Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study. Co-author DOI 10.3389/fimmu.2025.1571182↗
  3. Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cance… Co-author DOI 10.1158/0008-5472.can-24-0830↗
  4. Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells. Co-author DOI 10.1186/s13046-024-03060-5↗
  5. Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-024-03178-6↗
  6. Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-024-03192-8↗
  7. Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis. Co-author DOI 10.1111/cas.15901↗
  8. Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer. Co-author DOI 10.1186/s12885-022-10207-0↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohei Nakata · 8 shared papers, 2022–2025 · strength 1.36
  2. Chika Iwamoto · 7 shared papers, 2023–2025 · strength 1.22
  3. Naoki Ikenaga · 7 shared papers, 2023–2025 · strength 1.22
  4. Toshiya Abe · 6 shared papers, 2023–2025 · strength 1.04
  5. Kenoki Ohuchida · 6 shared papers, 2023–2025 · strength 1.03
  6. Yoshinao Oda · 5 shared papers, 2023–2024 · strength 0.82
  7. Chikanori Tsutsumi · 4 shared papers, 2024–2025 · strength 0.71
  8. Masataka Hayashi · 4 shared papers, 2023–2024 · strength 0.63
  9. Haizhen Luo · 4 shared papers, 2023–2024 · strength 0.63
  10. Pingshan Zhong · 4 shared papers, 2023–2024 · strength 0.63
  11. Masafumi Nakamura · 4 shared papers, 2022–2024 · strength 0.61
  12. Yuki Mochida · 3 shared papers, 2024–2025 · strength 0.55
  13. Noboru Ideno · 3 shared papers, 2024–2025 · strength 0.53
  14. Takashi Morisaki · 3 shared papers, 2024–2025 · strength 0.51
  15. Masafumi Nakamura · 2 shared papers, 2024–2025 · strength 0.39
  16. Tomohiko Shinkawa · 2 shared papers, 2024–2025 · strength 0.36
  17. Koji Shindo · 2 shared papers, 2024 · strength 0.35
  18. Hideya Onishi · 2 shared papers, 2024–2025 · strength 0.35
  19. Nao Fujimori · 2 shared papers, 2022–2025 · strength 0.34
  20. Kazuhiro Koikawa · 2 shared papers, 2024 · strength 0.32
  21. Yoshinao Oda · 1 shared paper, 2025 · strength 0.21
  22. Masafumi Nakamura · 1 shared paper, 2025 · strength 0.20
  23. Hiroto Tanaka · 1 shared paper, 2025 · strength 0.20
  24. Yusuke Nakamura · 1 shared paper, 2025 · strength 0.20
  25. Bo Zhang · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.